01 / HEALING TESTS IN RATS
Did BPC-157 help injured tendons and stomachs?
The peptide was made using a protein fragment from stomach fluid. This page explains improved rat healing and the much smaller reports involving people.
What is the short answer about healing?
Lab workers made BPC-157 as a peptide for healing research. Rat injuries improved; reports involving people leave the human healing benefit unproved.
Rats healed faster after their Achilles tendons were cut completely through [6]. The heel bone and calf muscle are attached by this tendon; researchers checked strength, movement and tissue repair.
Stomach ulcers in rats also healed better, especially with larger tested amounts [5]. These were injuries to the stomach lining, rather than wounds on the skin.
In 2025, reviewers described three small early reports of BPC-157 use in people [2]. The safety report involved just two adults, both healthy, without untreated adults for comparison [1].
There is no a careful human trial showing that BPC-157 heals tendons or stomach ulcers. The improved rat healing cannot tell you what happens to an injury in your body.
Removal of BPC-157 from the body was studied in rats and beagle dogs [3]. No published human study has measured how quickly a person removes the substance.
The findings in rats support more research, while leaving human help and harm unmeasured. A result about your own tendon or stomach needs testing in people with that injury.
Has this substance received medicine approval?
Papers use the name Body Protection Compound 157 for the substance called BPC-157. Fifteen amino acids make up the peptide, using the same small parts as proteins.
The substance withstands stomach acid, which helps explain why stomach injuries were studied. Older papers may write BPC 157 or use the earlier name PL 14736.
No country has approved BPC-157 for treating people. In 2023, the US Food and Drug Administration listed the substance as not allowed in pharmacy-made medicines pending review.
A review still being pending does not give pharmacies permission to use the substance now. The World Anti-Doping Agency also prohibits its use in sport, both during and between competitions.
Bottles offered for laboratory work have not been approved as treatments for people. That label doesn't tell you whether anyone checked what the bottle contains, how strong the contents are or whether germs are present.
A trial using a known substance cannot establish what an unapproved bottle contains. The review published in 2025 names these product unknowns among its concerns about BPC-157 [2].
The name on your bottle may be familiar while the actual contents remain unknown. Product checks and a published healing result answer separate questions about possible use in people.
Could a better blood supply explain the rat results?
Animal experiments and dish tests linked BPC-157 with more blood vessels growing in injured tissue. An improved blood supply could aid repair of your damaged tendon or stomach lining.
The work on BPC-157 examined proteins involved in blood vessel growth, not a person's recovery. In 2017, treated cells had more of those proteins than the cells used for comparison.
Researchers also followed the growth proteins as the treated cells took the proteins in. That movement was part of the growth response, rather than evidence that anyone's wound healed.
Researchers used developing chick tissue, along with dish-grown cells from humans. A separate rat test found blood returning faster to a back leg after an artery was blocked [4].
When researchers stopped the cells taking in the growth proteins, the growth response stopped too. This helped explain the dish results, but doesn't tell you whether treatment repairs a human injury.
Other experiments checked whether tendon cells moved towards wounds or responded differently to growth hormone. Growth hormone carries messages that promote growth; treated tendon cells responded more readily to hormone already present.
A review in 2016 discussed how rodents' brains communicate with their digestive organs [7]. In those animals, BPC-157 changed brain chemicals affecting mood as well as movement.
These findings concern animals or isolated cells, leaving the response of a whole person unknown. Human cells in a dish are not the same as treatment tested in living people.
Your injury needs a study that measures recovery in people with a comparable injury. A possible reason for rat healing cannot establish either human healing or lasting human safety.
What happened in the main healing and safety tests?
Rat experiments showed improved healing, while the human safety report followed very few people. The animal results come with a limit: your injury hasn't had the same human testing.
Stomach wounds in rats, 2004: BPC 157 reduced ulcers and improved repair of the stomach lining. Treatment injected into muscle worked better than treatment put straight into the stomach [5].
The larger tested amounts brought better repair, including tissue around the ulcers. Neither that benefit nor that difference between ways of giving treatment has been shown in people.
Cut tendons in rats, 2003: BPC-157 improved healing in tendons cut right through compared with untreated tendons [6]. The Achilles tendon attaches the calf muscle at the heel bone; strength, movement and tissue repair improved.
Collagen, a protein that helps give tendons their strength, was arranged more normally. Rat tendon cells also grew faster in dishes, leaving both findings unconfirmed in people.
Blood supply tests, 2017: The team used chick tissue, dish-grown human cells and rats with blocked leg arteries [4]. Blood returned to the rat legs sooner, and the tests found new vessels forming.
The human cells stayed in dishes throughout that experiment, outside a living person's body. Your question about years of increased vessel growth hasn't been answered by those short experiments.
Removal from animals, 2022: Within less than 30 minutes, half the substance was gone from their bodies [3]. After muscle shots, about 14 to 19 percent reached the blood in rats.
For dogs, the share reaching blood after muscle shots was about 45 to 51 percent. The substance broke into smaller pieces, and waste passed out in urine and bile.
Bile is digestive fluid that reaches the bowel, where some waste leaves with stool. The roughly threefold animal difference leaves entry into your blood and removal from your body uncertain.
Small human safety report, 2025: In the report, two adults received BPC-157 through a vein, up to 20 milligrams [1]. The adults were a 58-year-old man and a 68-year-old woman.
No side effects were detected, and tests of kidneys, liver, heart and blood sugar showed no change. Thyroid tests also stayed unchanged; this neck gland helps control how fast the body uses energy.
Each adult received treatment once, with no untreated group and no check of wound healing. Such a short report can't reliably find rare harm or harm from repeated treatment.
Earlier research reviewed, 2025: A 2025 review found much animal work and little reliable human evidence [2]. Missing large human trials and uncertain product contents led the authors to urge caution.
The review considered already published work rather than treating a new group of people. Its findings leave you with little human evidence about either healing or safety.
Brain and digestion papers, 2016: A review examined BPC 157 work on communication inside rodents [7]. Changes involving their brains and digestion don't establish the same changes or benefits in people.
Much early BPC-157 work was done by one team working with its partners. Reviewers noted that unrelated teams had not widely repeated those findings [2].
Which reports of benefits and problems remain unproved?
People trying BPC-157 research material have described changes online and in clinic accounts. A controlled study hasn't tested these accounts or established what was in the bottles used.
People most often describe trying the substance for lasting tendon, ligament or joint trouble. They commonly report less pain with movement and less stiffness during the first one to three weeks.
A tendon attaches muscle at a bone; ligaments keep the bones within a joint together. Without an untreated comparison group, those accounts can't establish repair or show what caused the pain change.
Some people report less bloating, fewer cramps and less urgent bowel movements within a week or two. They connect that improvement with the substance's stomach origin, but the reports don't test that explanation.
Less common accounts describe improved sleep, steadier mood or skin wounds closing faster. Reports of reduced inflammation, or swelling and irritation, may also reflect expecting treatment to work.
A red, stinging or slightly raised spot at the spot that received the shot is often reported. People generally describe the spot fading within a day, rather than remaining sore.
Stomach upset and nausea, meaning feeling sick, are common with swallowed products or products left beneath the tongue. Other complaints include tiredness, headache, dizziness on standing and flushing, a brief warm reddening of the skin.
Accounts often blame the warmth on blood vessel changes without checking that cause. In rare accounts, people describe their heart racing or pounding, sometimes leading to a doctor's examination.
People describe stopping after a continuing fast heartbeat, chest pain or a marked blood-pressure change. Those personal decisions don't establish the safety of a product or of further use.
Small reports and the 2025 review leave the human benefit and risks unsettled [1][2]. Most healing evidence comes from rodents, without large human studies comparing treated and untreated injuries.
Much of the early research came from the same team [2]. Your confidence would be stronger if unrelated teams repeated the findings in separate studies.
An unapproved bottle may contain a substance other than the one used in research, and BPC-157 has no medicine approval [2]. A rat experiment cannot establish what is in your bottle.
Growing blood vessels can also supply tumours, creating a possible concern about cancer [4]. No human study has established whether the substance causes that harm.
Rodent experiments found changes in serotonin, a brain chemical affected by some medicines [7]. Taking the substance alongside those medicines has not been tested in people.
Tendon cells responded more readily to existing growth hormone in lab tests. Lasting unwanted tissue growth is a question that human follow-up hasn't settled.
The World Anti-Doping Agency prohibits the substance throughout the year, including between competitions. There also isn't evidence establishing safety for children, pregnancy or breastfeeding.
What is missing before rat healing can mean human healing?
BPC-157 experiments showed several kinds of improved healing and possible reasons for the improvement. Those results need a human trial that fairly compares treated and untreated injuries.
A stronger rat tendon doesn't show that the treatment strengthens your injured tendon. A human recovery study would need to check benefit and harm together.
Retatrutide has large trials involving people, although the drug still lacks approval. PT-141 has approval for a particular use and 52-week safety checks.
The small BPC-157 safety report gave treatment through a vein to only two adults [1]. Reviewers found the larger human healing studies still missing [2].
Human testing hasn't measured the time taken for a person to remove the substance. In animals, half the substance was gone within less than 30 minutes [3].
After muscle shots, the share reaching blood differed roughly threefold between rats and dogs. Those animal findings cannot establish an amount or timing for people.
A confident online account cannot supply the missing human measurement. The evidence compared across four substances shows why each still leaves a different question open.